Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Condition:   Endocarditis Infective Interventions:   Drug: Cefaclor;   Drug: Ciprofloxacin Tablets;   Drug: Ciprofloxacin Injection;   Drug: Clindamycin Oral Capsule;   Drug: Clindamycin Injection;   Drug: Dicloxacillin Oral Capsule;   Drug: Dicloxacillin;   Drug: Fusidic Acid Only Product in Oral Dose Form;   Drug: F usidic Acid Only Product in Parenteral Dose Form;   Drug: Levofloxacin Oral Tablet;   Drug: Levofloxacin Injection;   Drug: Linezolid Oral Tablet;   Drug: Linezolid Injectable Product;   Drug: Moxifloxacin tablet;   Drug: Moxifloxacin Injectable Product;   Drug: Rifampicin O nly Product in Oral Dose Form;   Drug: Rifampicin Only Product in Parenteral Dose Form;   Drug: Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim];   Drug: Sulfamethoxazole / Trimethoprim Injectable Product;   Drug: Tedizolid Oral Tablet;   Drug: Tedizolid Injection;   Drug: Amox icillin Capsules;   Drug: Amoxicillin;   Drug: Cefaclor Capsules Sponsor:   Fundacion Clinic per a la Recerca Biomédica Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials